Michael Geffner, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 5,314 shares at $23.59 ($125K) on 2025-01-22, disclosed to the SEC on 2025-01-24.
Open-market sale of $125k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.59 | 2,657 | $63K | 50.0% |
| 2 | $23.59 | 2,657 | $63K | 50.0% |
| Total | $23.59 avg | 5,314 | $125K | 100% |
| Filing → |
| IMVT | SELL | 2025-07-25 | $43K | — | Filing → |
| IMVT | SELL | 2025-07-11 | $20K | — | Filing → |
| IMVT | SELL | 2025-04-25 | $35K | — | Filing → |